Objectives-Antiperinuclear factor (APF), antikeratin antibodies (AKA), and anti-RA 33 antibodies are currently considered to be good markers for the diagnosis of adult rheumatoid arthritis with or without rheumatoid factor (RF). 
determine whether they were associated with specific features. Methods-One hundred and twenty-four patients with JCA participated in this study. Controls included 28 RA, no relation was found between the presence of AKA and disease severity or activity. Conclusion-These data suggest that APF, AKA, and anti-RA 33 Antikeratin antibodies are complement fixing IgG antibodies directed against the stratum corneum of rat oesophagus squamous cells.5 16 Evidence suggests that the keratin antigen shares some homology with the C terminal portion of the heterogeneous nuclear RNP protein Al.7 These antibodies have been detected in 36-69% of patients with RA5 "'15 16 18-22 and in 5-47% of seronegative patients with RA.5 11 16 20 23 Antikeratin antibodies were shown to be highly specific for RA when detected in synovial fluid.24 They were found in the serum of O-8% of healthy controls and patients with other rheumatic disorders. 5 19-21 23 24 Higher percentages were also reported in subjects with progressive systemic sclerosis22 25 Among patients with pauciarticular onset JCA, those with persistent pauciarticular disease were defined as having a cumulative total of four or fewer affected joints over the entire period of follow up, whereas those who subsequently converted to a polyarticular course were defined as having a cumulative total of more than five affected joints. Chronic uveitis was defined as the presence of typical signs on slit lamp examination (performed two to three times a year in all patients with pauciarticular onset JCA during follow up). Physical examination with particular attention to the presence of active inflammatory osteoarticular features was performed at the time of serum collection. Erythrocyte sedimentation rate (ESR) was also measured in 109 of the 124 patients.
Control patients included 21 children without rheumatic disease nor inflammatory disorders and 28 children with SLE. Antikeratin antibodies were detected in 27% of With the exception of one patient with polyarticular seropositive onset, dilution titres of serum samples positive for AKA ranged from 1:20 to 1:160 in patients with JCA, whereas these values are generally higher in adult RA, reaching 1:1000 in some instances. Dilution titres found in our study were compared with those in 14 RA serum samples positive for AKA assessed at the same time. Dilution titres in the RA serum samples positive for AKA were significantly higher than those found in our patients with JCA (data not shown). These results are in accordance with previous reports showing that high dilution titres of AKA are pathognomonic for adult RA 16 20 Results of tests for ANA performed before and during the study in patients with JCA and in healthy controls are shown in table 4. As previously reported,35 these antibodies were found in significantly higher percentages of the pauciarticular and seropositive polyarticular onset subgroups than in controls (p<001 and p<00001 respectively). Antinuclear antibody status was independent of the results of tests for other antibodies ( It has been shown that the sensitivity of the APF test for the diagnosis of adult RA can be increased by pretreating cells with the detergent Triton-X1 00.3 This procedure reduces specificity, however. We therefore did not use Triton-X100 in our assay. Furthermore, as found by Von Essen et al, 29 Triton-X100 did not increase the sensitivity ofAPF for the diagnosis of JCA.
Nesher et al reported that the prevalence of APF varies across populations.38 Our patients were ethnically diverse and, consequently, it is unlikely that our results were due to a selection of a particular ethnic group.
The presence of AKA was significant only in a subset of patients with RF negative polyarticular onset JCA compared with healthy controls. The sensitivity of AKA was, however, rather poor, not exceeding 50%. In addition, AKA could not be considered specific for this subset of JCA as the percentages of serum samples positive for AKA did not differ significantly across JCA subgroups. In contrast with previous reports in adult RA,16 18 20 21 23 AKA status was not related to disease activity or severity. The value of our result is, however, limited by the fact that our patients were not followed up longitudinally.
Anti-RA 33 antibodies have been previously reported as strongly specific for the diagnosis of RA.27 In one study, however, anti-RA 33 antibodies were also detected in patients with other rheumatic disorders, including in 60% of patients with mixed connective tissue disease and 25% of those with SLE (unpublished data). Our findings in children with SLE are thus in accordance with results in adults. The rate of anti-RA 33 positivity was significant only in patients with RF positive polyarticular onset JCA, a fact which limits the value of this test. This finding requires confirmation because of the small number of patients in this subgroup.
In conclusion, our results show that APF, AKA, and anti-RA 33 antibodies do not contribute to the diagnosis or classification of JCA, which still relies mainly on clinical findings and on the presence of RF and ANA. These data are at variance with those found in adult RA serum samples, suggesting that, with the exception of a subset of patients with RF positive polyarticular onset JCA, JCA is a heterogeneous entity different from adult RF positive RA. 
